Human insulin analogues modified at the B26 site reveal a hormone conformation that is undetected in the receptor complex

[AsnB26]- and [GlyB26]-insulin mutants attain a B26-turn like fold without assistance of chemical modifications. Their structures match the insulin receptor interface and expand the spectrum of insulin conformations.